Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreOur team of pathway transformation consultants evaluate how care is being administered on the front line and identify the root causes of variation, barriers, and bottlenecks currently preventing asset adoption.
PATHFINDER is a collaborative initiative between NHS, IQVIA and AstraZeneca), using an in-depth data-informed approach to provide the NHS the time and space to streamline lung cancer pathways.
PATHFINDER is helping the NHS to move closer to achieving the best practices set out in the National Optimal Lung Cancer Pathway (NOLCP). The aim is to cure more patients with lung cancer.
Quantify the Opportunity
Identify the Patient
Implement the Change
Understand the Environment
Support the Patient
Accelerating patient access to optimal care
